Open the mobile version, with barcode scanning
Class II Terminated

Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1 Wallet of 28 Tablets (NDC 68180-857-11), 3 Wallets of 28 Tablets Each per carton (ND…

Why: Failed Content Uniformity Specifications: Out Of Specification test results observed for content uniformity.

Company
Lupin Pharmaceuticals Inc.
Baltimore, MD, United States
Reported
Mar 18, 2020
Recall started
Mar 9, 2020
Ended
May 25, 2021
Where sold
Nationwide in the USA and Puerto Rico.
Amount
9,897 cartons
Full product description
Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1 Wallet of 28 Tablets (NDC 68180-857-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-857-13); Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.
Lots / codes affected
Lot #: L800951, Exp July 2020

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.